News

June 2024: Visualizing Market Dynamics – Mid-Year Edition

Foundry Partners has released a thought leadership paper titled "Visualizing Market Dynamics: A Guide to Market Trends" This paper attempts to provide a snapshot for investors through a handful of visualizations on various macro drivers impacting the markets today.

June 2024: Visualizing Market Dynamics – Mid-Year Edition2024-06-13T20:33:59+00:00

February 2024: Active and Passive Investing – Navigating Cycles and Hidden Risks

Foundry Partners has released a new thought leadership paper titled "Active & Passive Investing: Navigating Cycles and Hidden Risks." The paper delves into the history of passive investing, the relationships and cyclicality of active and passive management, and some of the risks or pitfalls that might not be accounted for with a dedicated passive approach.

February 2024: Active and Passive Investing – Navigating Cycles and Hidden Risks2024-06-13T20:27:39+00:00

December 2023: Visualizing Market Dynamics – Year-End Edition

Foundry Partners has released a thought leadership paper titled "Visualizing Market Dynamics: A Guide to Market Trends - Year End." This paper attempts to provide a snapshot for investors through a handful of visualizations on various macro drivers impacting the markets today.

December 2023: Visualizing Market Dynamics – Year-End Edition2024-02-07T16:50:59+00:00

September 11, 2023: Weighing Risk & Reward

Foundry Partners has released a thought leadership paper titled "Weighing Risk & Reward: The Intersection Where Art Meets Science." This paper looks at the markets and examines how there are factors at play that are part art and part science, and how both skills are needed to improve the odds of success.

September 11, 2023: Weighing Risk & Reward2023-12-20T20:02:02+00:00

July 2023: Visualizing Market Dynamics

Foundry Partners has released a thought leadership paper titled "Visualizing Market Dynamics: A Guide to Market Trends." This paper attempts to provide a snapshot for investors through a handful of visualizations on some of the most influential macro drivers impacting the markets today.

July 2023: Visualizing Market Dynamics2023-09-11T15:35:40+00:00

February 23, 2023: Foundry Partners Named to PSN Top Guns List

Foundry Partners LLC announced that it has been named to the celebrated PSN Top Guns List of best performing separate accounts, managed accounts, and managed ETF strategies for Q4 2022.

February 23, 2023: Foundry Partners Named to PSN Top Guns List2023-07-06T20:34:49+00:00

February 14, 2023: The Power of Narratives

Foundry Partners has released a thought leadership paper titled "The Power of Narratives: How stories shape investor behaviors." The paper was authored by Mark Roach and Mario Tufano (CFA) and marks the third and final installment discussing the investment process utilized by Foundry's Fundamental team.

February 14, 2023: The Power of Narratives2023-02-23T21:04:15+00:00

February 1, 2023: Foundry Partners Celebrates 10 Years

On February 1, 2003 Foundry Partners commenced operations. Over the last 10 years the firm has had the privilege of working with many clients throughout the country.  Since our inception, the culture of Foundry Partners has been the single most important driving force of our success. 

February 1, 2023: Foundry Partners Celebrates 10 Years2023-02-14T16:39:37+00:00

December 15, 2022: Is Quality Investing Back En Vogue

Foundry Partners has released a thought leadership paper titled "Is Quality Investing Back "En Vogue": In the current economic landscape, is now still the time for "quality" to shine." We encourage you to take a look and read the full paper.

December 15, 2022: Is Quality Investing Back En Vogue2023-02-01T19:03:06+00:00

September 1, 2022: The Pharma/Biotech Dilemma

Foundry Partners has released a thought leadership paper titled "The Pharma/Biotech Dilemma: How current Small and Microcap Index weightings in the pharma and biotech industries are creating a dilemma for traditional value managers." We encourage you to take a look and read the full paper.

September 1, 2022: The Pharma/Biotech Dilemma2022-12-15T22:29:33+00:00
Go to Top